Suppr超能文献

用于生物医学创新的工程化四面体框架核酸的进展。

Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations.

作者信息

Fan Qin, Sun Bicheng, Chao Jie

机构信息

State Key Laboratory for Organic Electronics & Information Displays (KLOEID), Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM) and School of Materials Science and Engineering, Nanjing University of Posts & Telecommunications, Nanjing, 210000, China.

Portland Institute, Nanjing University of Posts and Telecommunications, Nanjing, 210000, China.

出版信息

Small Methods. 2024 Nov 1:e2401360. doi: 10.1002/smtd.202401360.

Abstract

Tetrahedral framework nucleic acids (tFNAs) are renowned for their controllable self-assembly, exceptional programmability, and excellent biocompatibility, which have led to their widespread application in the biomedical field. Beyond these features, tFNAs demonstrate unique chemical and biological properties including high cellular uptake efficiency, structural bio-stability, and tissue permeability, which are derived from their distinctive 3D structure. To date, an extensive range of tFNA-based nanostructures are intelligently designed and developed for various biomedical applications such as drug delivery, gene therapy, biosensing, and tissue engineering, among other emerging fields. In addition to their role in drug delivery systems, tFNAs also possess intrinsic properties that render them highly effective as therapeutic agents in the treatment of complex diseases, including arthritis, neurodegenerative disorders, and cardiovascular diseases. This dual functionality significantly enhances the utility of tFNAs in biomedical research, presenting valuable opportunities for the development of next-generation medical technologies across diverse therapeutic and diagnostic platforms. Consequently, this review comprehensively introduces the latest advancements of tFNAs in the biomedical field, with a focus on their benefits and applications as drug delivery nanoplatforms, and their inherent capabilities as therapeutic agents. Furthermore, the current limitations, challenges, and future perspectives of tFNAs are explored.

摘要

四面体框架核酸(tFNA)以其可控的自组装、出色的可编程性和优异的生物相容性而闻名,这些特性使其在生物医学领域得到了广泛应用。除了这些特性外,tFNA还表现出独特的化学和生物学性质,包括高细胞摄取效率、结构生物稳定性和组织渗透性,这些性质源于其独特的三维结构。迄今为止,人们已经为药物递送、基因治疗、生物传感和组织工程等各种生物医学应用以及其他新兴领域,智能设计并开发了广泛的基于tFNA的纳米结构。除了在药物递送系统中的作用外,tFNA还具有内在特性,使其在治疗包括关节炎、神经退行性疾病和心血管疾病在内的复杂疾病方面作为治疗剂非常有效。这种双重功能显著提高了tFNA在生物医学研究中的实用性,为跨不同治疗和诊断平台的下一代医疗技术的发展提供了宝贵机遇。因此,本综述全面介绍了tFNA在生物医学领域的最新进展,重点关注其作为药物递送纳米平台的优势和应用,以及其作为治疗剂的内在能力。此外,还探讨了tFNA目前的局限性、挑战和未来展望。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验